Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,632,200 | 1,365,500 | 977,000 | 393,400 | 1,161,500 |
| Depreciation Amortization | 903,200 | 694,500 | 440,600 | 191,600 | 526,300 |
| Income taxes - deferred | -158,100 | -99,700 | -47,100 | 39,900 | -305,800 |
| Accounts receivable | 222,300 | 127,600 | 12,300 | 43,700 | 61,300 |
| Other Working Capital | -155,200 | -183,500 | -417,300 | -228,700 | -648,700 |
| Other Operating Activity | 431,100 | 210,200 | 213,500 | 113,300 | 752,600 |
| Operating Cash Flow | $2,875,500 | $2,114,600 | $1,179,000 | $553,200 | $1,547,200 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -153,700 | -114,400 | -79,400 | -45,900 | -277,000 |
| Net Acquisitions | -1,074,800 | -668,000 | 406,800 | N/A | -6,926,100 |
| Purchase Of Investment | N/A | 0 | N/A | N/A | -5,140,700 |
| Sale Of Investment | 551,500 | 96,700 | 57,500 | 55,600 | 8,288,500 |
| Purchase Sale Intangibles | -206,100 | -179,100 | -84,100 | -75,000 | -34,400 |
| Other Investing Activity | -122,200 | -94,900 | 15,600 | -75,700 | -45,700 |
| Investing Cash Flow | $-799,200 | $-780,600 | $400,500 | $-66,000 | $-4,101,000 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 0 | 0 | N/A | 997,200 |
| Debt Repayment | -650,000 | -650,000 | -650,000 | -400,000 | -809,900 |
| Other Financing Activity | -33,500 | -41,400 | -34,800 | -39,600 | -38,000 |
| Financing Cash Flow | $-683,500 | $-691,400 | $-684,800 | $-439,600 | $149,300 |
| Exchange Rate Effect | -67,700 | 6,700 | -35,700 | -23,100 | 35,100 |
| Beginning Cash Position | 1,049,900 | 1,049,900 | 1,049,900 | 1,049,900 | 3,419,300 |
| End Cash Position | 2,375,000 | 1,699,200 | 1,908,900 | 1,074,400 | 1,049,900 |
| Net Cash Flow | $1,325,100 | $649,300 | $859,000 | $24,500 | $-2,369,400 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,875,500 | 2,114,600 | 1,179,000 | 553,200 | 1,547,200 |
| Capital Expenditure | -153,700 | -114,400 | -79,400 | -45,900 | -277,000 |
| Free Cash Flow | 2,721,800 | 2,000,200 | 1,099,600 | 507,300 | 1,270,200 |